Simplex Trading
SWTX

Simplex Trading’s SpringWorks Therapeutics SWTX Stock Holding History

Simplex Trading’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-145,500
Closed -$29K – 10038
2025
Q2 		$29K Sell
145,500
-377,400
-72% -$16.8M ﹤0.01% 6440
2025
Q1 		$23.1M Buy
522,900
+514,400
+6,052% +$23.7M 0.01% 478
2024
Q4 		$307K Buy
8,500
+1,400
+20% +$48.9K ﹤0.01% 4045
2024
Q3 		$227K Buy
7,100
+4,900
+223% +$183K ﹤0.01% 4407
2024
Q2 		$82K Buy
2,200
+200
+10% +$8.42K ﹤0.01% 5580
2024
Q1 		$98K Sell
2,000
-13,300
-87% -$615K ﹤0.01% 5599
2023
Q4 		$558K Buy
15,300
+14,200
+1,291% +$371K ﹤0.01% 3579
2023
Q3 		$25K Sell
1,100
-4,100
-79% -$112K ﹤0.01% 6439
2023
Q2 		$136K Sell
5,200
-34,900
-87% -$917K ﹤0.01% 4727
2023
Q1 		$1.03M Buy
40,100
+7,100
+22% +$208K ﹤0.01% 2563
2022
Q4 		$858K Sell
33,000
-12,200
-27% -$301K ﹤0.01% 2617
2022
Q3 		$1.29M Buy
45,200
+41,800
+1,229% +$1.2M ﹤0.01% 2364
2022
Q2 		$83K Sell
3,400
-50,500
-94% -$1.85M ﹤0.01% 5817
2022
Q1 		$3.04M Buy
+53,900
New +$3.08M ﹤0.01% 1684

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplex Trading's SWTX Position: Q2 2025 in Review

Simplex Trading sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 46,435 shares — an estimated $2.07M sold.

Simplex Trading first reported a position in SWTX in Q2 2022 and held it in 8 quarters. The position peaked at $2.05M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Simplex Trading reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 46,435 SpringWorks Therapeutics shares in Q2 2025, an estimated $2.07M.
  • Simplex Trading first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 8 quarters.
  • Simplex Trading's SpringWorks Therapeutics position peaked at $2.05M in Q1 2025.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.